| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.759.160.918 $ | +112.779.605 $ | +0,2 % | 26 | 1.961.136.508 $ | +405.527.550 $ | +21,4 % | 27 | 1.822.265.067 $ | +507.772.292 $ | +69,2 % | 29 | ||||
| Celcuity Inc. | CELC | → 0 | Schwach | 260.873.933 $ | -91.762.921 $ | -26,0 % | 1 | 352.636.854 $ | +246.710.361 $ | +232,9 % | 1 | 105.926.493 $ | +75.298.109 $ | +245,8 % | 1 |
| Arcellx, Inc. | ACLX | → 0 | 349.656.983 $ | +151.105.901 $ | +76,1 % | 1 | 198.551.082 $ | -51.464.928 $ | -20,6 % | 1 | 250.016.010 $ | +3.390.507 $ | +1,4 % | 1 | |
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Schwach | 311.481.690 $ | +17.605.234 $ | +6,0 % | 1 | 293.876.456 $ | +109.996.336 $ | +59,8 % | 1 | ||||
| Verona Pharma plc | VRNA | → 0 | 240.416.990 $ | +26.369.398 $ | +12,3 % | 1 | |||||||||
| SpyGlass Pharma, Inc. | SGP | → 0 | Neutral | 191.534.519 $ | +191.534.519 $ | 1 | |||||||||
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 157.741.180 $ | -7.801.115 $ | -4,7 % | 1 | 165.542.295 $ | +44.558.909 $ | +36,8 % | 1 | 120.983.386 $ | +48.657.798 $ | +67,3 % | 1 |
| Coursera, Inc. | COUR | → 0 | Stark | 74.890.416 $ | -19.816.364 $ | -20,9 % | 1 | 94.706.780 $ | -55.974.795 $ | -37,1 % | 1 | 150.681.575 $ | +37.959.919 $ | +33,7 % | 1 |
| Savara Inc | SVRA | → 0 | Neutral | 133.613.101 $ | -13.948.621 $ | -9,5 % | 1 | 147.561.722 $ | +60.199.310 $ | +68,9 % | 1 | 87.362.412 $ | +31.567.930 $ | +56,6 % | 1 |
| Zenas BioPharma, Inc. | ZBIO | → 0 | Neutral | 78.653.931 $ | -49.274.151 $ | -38,5 % | 1 | 127.928.082 $ | +67.239.520 $ | +110,8 % | 1 | 60.688.562 $ | +34.198.825 $ | +129,1 % | 1 |
| Monte Rosa Therapeutics, Inc. | GLUE | → 0 | Schwach | 126.538.302 $ | +5.923.069 $ | +4,9 % | 1 | 120.615.233 $ | +63.615.305 $ | +111,6 % | 1 | 56.999.928 $ | +22.307.664 $ | +64,3 % | 1 |
| MBX Biosciences, Inc. | MBX | → 0 | Schwach | 107.892.407 $ | -6.108.481 $ | -5,4 % | 1 | 114.000.888 $ | +50.747.383 $ | +80,2 % | 1 | 63.253.505 $ | +22.012.220 $ | +53,4 % | 1 |
| CRISPR Therapeutics AG | CRSP | → 0 | Schwach | 50.356.175 $ | -5.155.236 $ | -9,3 % | 1 | 55.511.411 $ | -13.094.511 $ | -19,1 % | 1 | 68.605.922 $ | -8.627.297 $ | -11,2 % | 1 |
| Aurinia Pharmaceuticals Inc. | AUPH | → 0 | Stark | 58.832.940 $ | -4.485.912 $ | -7,1 % | 1 | 63.318.852 $ | +19.452.186 $ | +44,3 % | 1 | 43.866.666 $ | +10.242.172 $ | +30,5 % | 1 |
| Gossamer Bio, Inc. | GOSS | → 0 | Sehr schwach | 328.500 $ | -55.759.905 $ | -99,4 % | 1 | 56.088.405 $ | +8.503.726 $ | +17,9 % | 1 | 47.584.679 $ | +25.330.247 $ | +113,8 % | 1 |
| Korro Bio, Inc. | KRRO | → 0 | Schwach | 14.692.149 $ | +5.954.897 $ | +68,2 % | 1 | 8.737.252 $ | -43.500.825 $ | -83,3 % | 1 | 52.238.077 $ | +38.614.072 $ | +283,4 % | 1 |
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Sehr schwach | 52.182.928 $ | +18.492.608 $ | +54,9 % | 1 | 33.690.320 $ | -15.733.132 $ | -31,8 % | 1 | 49.423.452 $ | +7.619.449 $ | +18,2 % | 1 |
| Phathom Pharmaceuticals, Inc. | PHAT | → 0 | Schwach | 21.777.478 $ | -10.741.726 $ | -33,0 % | 1 | 32.519.204 $ | +9.448.015 $ | +41,0 % | 1 | 23.071.189 $ | +4.273.168 $ | +22,7 % | 1 |
| CVRx, Inc. | CVRX | → 0 | Schwach | 19.166.745 $ | +4.781.556 $ | +33,2 % | 1 | 14.385.189 $ | -1.965.301 $ | -12,0 % | 1 | 16.350.490 $ | +4.437.122 $ | +37,2 % | 1 |
| NeueHealth, Inc. | NEUE | → 0 | 18.188.536 $ | -627.191 $ | -3,3 % | 1 | |||||||||
| Black Diamond Therapeutics, Inc. | BDTX | → 0 | Stark | 9.475.852 $ | -1.334.628 $ | -12,3 % | 1 | 10.810.480 $ | -6.050.309 $ | -35,9 % | 1 | 16.860.789 $ | +5.827.872 $ | +52,8 % | 1 |
| X4 Pharmaceuticals, Inc | XFOR | → 0 | Neutral | 13.355.359 $ | +420.387 $ | +3,3 % | 1 | 12.934.972 $ | +5.295.571 $ | +69,3 % | 1 | 7.639.401 $ | +6.690.239 $ | +704,9 % | 1 |
| CHAMPIONS ONCOLOGY, INC. | CSBR | → 0 | 9.853.890 $ | -1.987.915 $ | -16,8 % | 1 | 11.841.805 $ | +745.468 $ | +6,7 % | 1 | 11.096.337 $ | -1.533.779 $ | -12,1 % | 1 | |
| Inventiva S.A. | IVA | → 0 | Schwach | 8.029.597 $ | +1.228.572 $ | +18,1 % | 1 | 6.801.025 $ | -1.521.798 $ | -18,3 % | 1 | 8.322.823 $ | +3.657.174 $ | +78,4 % | 1 |
| Omada Health, Inc. | OMDA | → 0 | Neutral | 8.050.583 $ | +1.387.278 $ | +20,8 % | 1 | ||||||||
| Nkarta, Inc. | NKTX | → 0 | Neutral | 7.530.128 $ | +927.883 $ | +14,1 % | 1 | 6.602.245 $ | -785.132 $ | -10,6 % | 1 | 7.387.377 $ | +1.463.201 $ | +24,7 % | 1 |
| Senti Biosciences Holdings, Inc. | SNTI | → 0 | 3.065.799 $ | -860.841 $ | -21,9 % | 1 | 3.926.640 $ | -1.396.977 $ | -26,2 % | 1 | 5.323.617 $ | -2.642.931 $ | -33,2 % | 1 | |
| SYNLOGIC, INC. | SYBX | → 0 | 3.273.505 $ | -1.601.679 $ | -32,9 % | 1 | 4.875.184 $ | +1.163.263 $ | +31,3 % | 1 | |||||
| LeonaBio, Inc. | LONA | → 0 | 4.774.011 $ | +1.258.518 $ | +35,8 % | 1 | 3.515.493 $ | +3.515.493 $ | 1 | ||||||
| Marker Therapeutics, Inc. | MRKR | → 0 | 2.113.381 $ | -308.879 $ | -12,8 % | 1 | 2.422.260 $ | +971.180 $ | +66,9 % | 1 | 1.451.080 $ | -1.036.207 $ | -41,7 % | 1 | |
| OnKure Therapeutics, Inc. | OKUR | → 0 | Neutral | 1.981.189 $ | +593.400 $ | +42,8 % | 1 | 1.387.789 $ | +71.782 $ | +5,5 % | 1 | 1.316.007 $ | +172.277 $ | +15,1 % | 1 |
| ImageneBio, Inc. | IMA | → 0 | 250.025 $ | -95.010 $ | -27,5 % | 1 | 345.035 $ | -62.506 $ | -15,3 % | 1 | 407.541 $ | -396.543 $ | -49,3 % | 1 | |
| 1.759.160.918 $ | +112.779.605 $ | +0,2 % | 26 | 1.961.136.508 $ | +405.527.550 $ | +21,4 % | 27 | 1.822.265.067 $ | +507.772.292 $ | +69,2 % | 29 | ||||